Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig.
The effect of chronic administration of platelet-activating factor (PAF) on airway reactivity, cell recruitment and lung morphology in the guinea-pig has been investigated. Alzet osmotic minipumps delivering either PAF (7.2 mg/kg/14 days) in 0.25% (w/v) bovine serum albumin in saline (saline-BSA), acetylcholine or saline-BSA alone were implanted s.c. in the neck region of guinea-pigs and connected to the jugular vein. In some experiments, implanted and non-implanted animals were treated daily with the PAF antagonist, BN 52021 (15 mg/kg, twice a day, p.o.). On day 15 after minipump implantation, the animals were anesthetized with urethane (1.2 g/kg, i.p.) and tracheal cannula was inserted for mechanical ventilation. Pulmonary inflation pressure (PIP) was monitored and airway responsiveness was assessed by administration of increasing doses of histamine (0.2-100 micrograms/kg, i.v.). As compared to saline-BSA-treated or non-implanted guinea-pigs, chronic treatment of the animals with PAF induced a significant (p less than 0.01) increase in airway response. No significant change in airway responsiveness was observed following chronic acetylcholine administration. In contrast, regardless of the treatment of the animals, no change in the threshold dose of histamine inducing alteration in PIP was noted, suggesting that PAF induces bronchopulmonary hyperreactivity rather than hyperresponsiveness. In addition, no significant difference was observed in the in vitro responsiveness to histamine of lung parenchymal strips from animals having received PAF or saline-BSA.(ABSTRACT TRUNCATED AT 250 WORDS)
Touvay
C
C
Institut Henri Beaufour, Les Ulis, France.
Pfister
A
A
Vilain
B
B
Carré
C
C
Page
C P
CP
Lellouch-Tubiana
A
A
Pignol
B
B
Mencia-Huerta
J M
JM
Braquet
P
P
D000818:Animals; D001772:Blood Cell Count / Q000187:drug effects; D001980:Bronchi / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology; D046934:Ginkgolides; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008168:Lung / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013997:Time Factors
D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; D012710:Serum Albumin, Bovine; D006632:Histamine; C045856:ginkgolide B